An overview of microneedle applications, materials, and fabrication methods

• Zahra Faraji Rad,
• Philip D. Prewett and
• Graham J. Davies

Beilstein J. Nanotechnol. 2021, 12, 1034–1046, doi:10.3762/bjnano.12.77

• from cancer research (25% enhanced absorption of the protein cancer drug AvastinTM compared with conventional hypodermic delivery) [14]. Incorporation of drug-loaded nanoparticles in dissolving microneedles also shows promise for dose concentration, for example using the antimicrobial carvacrol (CAR

Differences in surface chemistry of iron oxide nanoparticles result in different routes of internalization

• Barbora Svitkova,
• Vlasta Zavisova,
• Veronika Nemethova,
• Martina Koneracka,
• Miroslava Kretova,
• Filip Razga,
• Monika Ursinyova and
• Alena Gabelova

Beilstein J. Nanotechnol. 2021, 12, 270–281, doi:10.3762/bjnano.12.22

• Barbora Svitkova Vlasta Zavisova Veronika Nemethova Martina Koneracka Miroslava Kretova Filip Razga Monika Ursinyova Alena Gabelova Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia Institute of Experimental

• . Plasmid CLLCb-pEGFP was kindly provided by Prof. Ernst J. Ungewickell (Department of Cell Biology, Centre of Anatomy, Hannover Medical School, Germany) and vector pcDNA 3.1 (+) was kindly provided by Katarina Luciakova, DSc. (Cancer Research Institute, Biomedical Research Center SAS, Bratislava, Slovakia

Cardiomyocyte uptake mechanism of a hydroxyapatite nanoparticle mediated gene delivery system

• Hiroaki Komuro,
• Masahiro Yamazoe,
• Kosuke Nozaki,
• Akiko Nagai and
• Tetsuo Sasano

Beilstein J. Nanotechnol. 2020, 11, 1685–1692, doi:10.3762/bjnano.11.150

• acquisition at inflammation sites. Further studies regarding the role of CaSR and its downstream signaling pathways in HL-1 cells are required. Although the HAp-based vector used here has a low transfection efficiency, it has already been used as a gene delivery system in in vivo cancer research experiments

Enhanced inhibition of influenza virus infection by peptide–noble-metal nanoparticle conjugates

• Zaid K. Alghrair,
• David G. Fernig and
• Bahram Ebrahimi

Beilstein J. Nanotechnol. 2019, 10, 1038–1047, doi:10.3762/bjnano.10.104

• , and North West Cancer Research. An earlier version of this work was published as a preprint (Alghrair, Z., Fernig, D. G.; Ebrahimi, B. Enhanced inhibition of influenza virus infection by peptide-noble metal nanoparticle conjugates. Biorxiv, 2018; doi:10.1101/324939).

Cytotoxicity of doxorubicin-conjugated poly[N-(2-hydroxypropyl)methacrylamide]-modified γ-Fe₂O₃ nanoparticles towards human tumor cells

• Zdeněk Plichta,
• Yulia Kozak,
• Rostyslav Panchuk,
• Viktoria Sokolova,
• Matthias Epple,
• Lesya Kobylinska,
• Pavla Jendelová and
• Daniel Horák

Beilstein J. Nanotechnol. 2018, 9, 2533–2545, doi:10.3762/bjnano.9.236

• Mouse melanoma cells of B16F10/wt line, human T-leukemia cells of Jurkat, K562, HL-60 lines and its drug-resistant HL-60/vinc sub-line (overexpression of P-glycoprotein) were a kind gift of Prof. Walter Berger, Institute of Cancer Research, Vienna Medical University (Austria). Human mesenchymal stem

Functional fusion of living systems with synthetic electrode interfaces

• Oskar Staufer,
• Sebastian Weber,
• C. Peter Bengtson,
• Hilmar Bading,
• Joachim P. Spatz and
• Amin Rustom

Beilstein J. Nanotechnol. 2016, 7, 296–301, doi:10.3762/bjnano.7.27

• Oskar Staufer Sebastian Weber C. Peter Bengtson Hilmar Bading Joachim P. Spatz Amin Rustom Max-Planck Institute for Intelligent Systems, Department of New Materials and Biosystems, Heisenbergstraße 3, D-70569 Stuttgart, Germany German Cancer Research Center, DKFZ Life Science Lab, Im Neuenheimer

Nanocuration workflows: Establishing best practices for identifying, inputting, and sharing data to inform decisions on nanomaterials

• Christina M. Powers,
• Karmann A. Mills,
• Stephanie A. Morris,
• Fred Klaessig,
• Sharon Gaheen,
• Nastassja Lewinski and
• Christine Ogilvie Hendren

Beilstein J. Nanotechnol. 2015, 6, 1860–1871, doi:10.3762/bjnano.6.189

• , Bethesda, MD 20892, USA Pennsylvania Bio Nano Systems, LLC, 69 Homestead Drive, Doylestown, PA 18901, USA Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, 8560 Progress Drive, Frederick, MD 21702, USA Department of Chemical and Life Science Engineering, Virginia

Analyzing collaboration networks and developmental patterns of nano-enabled drug delivery (NEDD) for brain cancer

• Ying Huang,
• Jing Ma,
• Alan L. Porter,
• Seokbeom Kwon and
• Donghua Zhu

Beilstein J. Nanotechnol. 2015, 6, 1666–1676, doi:10.3762/bjnano.6.169

• background on NEDD for brain cancer research. In the second part, search strategy and data are introduced. We focus on the scientific activity and collaboration network at the country, institution, and individual levels in the third section. In the conclusion, we make a brief summary of the research findings

• . Institutional co-authorship analysis In general, the research levels of a certain country depend on its leading institutions. Figure 4 shows the 12 leading institutions in NEDD for brain cancer research. Most institutions show good performance for the last 5 years, and Fudan University achieves an amazing

• technical decisions with the goal to enhance their technological innovation capabilities and international competitiveness. NEDD for brain cancer research across the disciplines. Publication trend of top 10 countries in 1990–2014. Scatter plot of international collaboration index (ICI) for top 10 countries

Experiences in supporting the structured collection of cancer nanotechnology data using caNanoLab

• Stephanie A. Morris,
• Sharon Gaheen,
• Michal Lijowski,
• Mervi Heiskanen and
• Juli Klemm

Beilstein J. Nanotechnol. 2015, 6, 1580–1593, doi:10.3762/bjnano.6.161

• Stephanie A. Morris Sharon Gaheen Michal Lijowski Mervi Heiskanen Juli Klemm Office of Cancer Nanotechnology Research, National Cancer Institute/NIH, 31 Center Drive, Bethesda, MD, 20892, USA Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, 8560 Progress Drive

• ; cancer research; databases; nanomaterials; nanomedicine; Introduction The U.S. annual report to the nation on the state of cancer indicates a steady decline in overall mortality rates, with increases in incidence for many cancers [1]. Internationally, cancer incidence paints a more dramatic picture in

Magnetic-Fe/Fe₃O₄-nanoparticle-bound SN38 as carboxylesterase-cleavable prodrug for the delivery to tumors within monocytes/macrophages

• Hongwang Wang,
• Tej B. Shrestha,
• Matthew T. Basel,
• Raj K. Dani,
• Gwi-Moon Seo,
• Sivasai Balivada,
• Marla M. Pyle,
• Heidy Prock,
• Olga B. Koper,
• Prem S. Thapa,
• David Moore,
• Ping Li,
• Viktor Chikan,
• Deryl L. Troyer and
• Stefan H. Bossmann

Beilstein J. Nanotechnol. 2012, 3, 444–455, doi:10.3762/bjnano.3.51

• data. Acknowledgements Support from NSF/ECCS 1128570 for VC and SHB is gratefully acknowledged. The authors from Kansas State University are thankful for financial support from the Terry C. Johnson Center for Cancer Research.